SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-027788
Filing Date
2024-02-27
Accepted
2024-02-27 06:01:59
Documents
4
Period of Report
2024-03-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm246018-2_def14a.htm DEF 14A 155851
2 GRAPHIC lg_quoinpharma-4clr.jpg GRAPHIC 8330
3 GRAPHIC px_24quoinproxy01page01-bw.jpg GRAPHIC 163442
4 GRAPHIC px_24quoinproxy01page02-bw.jpg GRAPHIC 191029
  Complete submission text file 0001104659-24-027788.txt   595103
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: DEF 14A | Act: 34 | File No.: 001-37846 | Film No.: 24681797
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)